COVID-19 and Cardiovascular Disease

This review summarises the rapidly evolving data in this field linking COVID-19 with increased morbidity and mortality from CVD, and it also reiterates that continuation of clinically indicated ACEIs and ARBs is recommended based on current evidence.

Source:

Circulation